| |
Original Artikel |
Datum |
Titel |
Autoren Alle Autoren |
| 1 |
[GO] |
2025―Apr―07 |
CD147-high classical monocytes: a cellular biomarker for COVID-19 disease severity and treatment response |
Teruaki Murakami, Yuta Yamaguchi, Saori Amiya, Yuko Yoshimine, Shinichiro Nameki, Yasutaka Okita, et al. (+5) Yasuhiro Kato, Haruhiko Hirata, Yoshito Takeda, Atsushi Kumanogoh, Takayoshi Morita |
| 2 |
[GO] |
2023―Jan―26 |
Innate immune recognition against SARS-CoV-2 |
Taisho Yamada, Akinori Takaoka |
| 3 |
[GO] |
2023―Jan―12 |
Humoral immunity for durable control of SARS-CoV-2 and its variants |
Ryutaro Kotaki, Saya Moriyama, Yoshimasa Takahashi |
| 4 |
[GO] |
2023―Jan―09 |
A review of Janus kinase inhibitors for the treatment of Covid-19 pneumonia |
Yoshiya Tanaka |
| 5 |
[GO] |
2022―Dez―05 |
Neutralizing and enhancing antibodies against SARS-CoV-2 |
Yafei Liu, Hisashi Arase |
| 6 |
[GO] |
2022―Nov―30 |
Next-generation proteomics of serum extracellular vesicles combined with single-cell RNA sequencing identifies MACROH2A1 associated with refractory COVID-19 |
Takahiro Kawasaki, Yoshito Takeda, Ryuya Edahiro, Yuya Shirai, Mari Nogami-Itoh, Takanori Matsuki, et al. (+20) Hiroshi Kida, Takatoshi Enomoto, Reina Hara, Yoshimi Noda, Yuichi Adachi, Takayuki Niitsu, Saori Amiya, Yuta Yamaguchi, Teruaki Murakami, Yasuhiro Kato, Takayoshi Morita, Hanako Yoshimura, Makoto Yamamoto, Daisuke Nakatsubo, Kotaro Miyake, Takayuki Shiroyama, Haruhiko Hirata, Jun Adachi, Yukinori Okada, Atsushi Kumanogoh |
| 7 |
[GO] |
2022―Nov―29 |
Current understanding of T cell immunity against SARS-CoV-2 |
Xiuyuan Lu, Sho Yamasaki |
| 8 |
[GO] |
2022―Nov―29 |
Association of cellular immunity with severity of COVID-19 from the perspective of antigen-specific memory T cell responses and cross-reactivity |
Shin-ichiro Fujii, Satoru Yamasaki, Tomonori Iyoda, Kanako Shimizu |
| 9 |
[GO] |
2022―Jun―01 |
Duration of SARS-CoV-2 RNA positivity from various specimens and clinical characteristics in patients with COVID-19: a systematic review and meta-analysis |
Yasutaka Okita, Takayoshi Morita, Atsushi Kumanogoh |
| 10 |
[GO] |
2021―Jul―23 |
Correction to: Renal complications in coronavirus disease 2019: a systematic review |
Taichiro Minami, Yasunori Iwata, Takashi Wada |
| 11 |
[GO] |
2021―Mai―07 |
Neurological pathogenesis of SARS-CoV-2 (COVID-19): from virological features to clinical symptoms |
Yoshitaka Kase, Hideyuki Okano |
| 12 |
[GO] |
2020―Dez―21 |
Correction to: Genome evolution of SARS-CoV-2 and its virological characteristics |
So Nakagawa, Takayuki Miyazawa |
| 13 |
[GO] |
2020―Dez―15 |
Renal complications in coronavirus disease 2019: a systematic review |
Taichiro Minami, Yasunori Iwata, Takashi Wada |
| 14 |
[GO] |
2020―Okt―12 |
Intensive diagnostic management of coronavirus disease 2019 (COVID-19) in academic settings in Japan: challenge and future |
Tokio Hoshina, Hiroka Aonuma, Manabu Ote, Tatsuya Sakurai, Erisha Saiki, Yuki Kinjo, et al. (+3) Kazuhiro Kondo, Masataka Okabe, Hirotaka Kanuka |
| 15 |
[GO] |
2020―Okt―12 |
Immunopathogenesis of SARS-CoV-2-induced pneumonia: lessons from influenza virus infection |
Masaaki Miyazawa |
| 16 |
[GO] |
2020―Okt―05 |
Outlook of IL-6 signaling blockade for COVID-19 pneumonia |
Misato Hashizume |
| 17 |
[GO] |
2020―Okt―01 |
How COVID-19 induces cytokine storm with high mortality |
Shintaro Hojyo, Mona Uchida, Kumiko Tanaka, Rie Hasebe, Yuki Tanaka, Masaaki Murakami, Toshio Hirano |
| 18 |
[GO] |
2020―Sep―15 |
Global health landscape challenges triggered by COVID-19 |
Hiroki Nakatani, Kei Katsuno, Hayato Urabe |
| 19 |
[GO] |
2020―Sep―11 |
Expression of ACE2 and a viral virulence-regulating factor CCN family member 1 in human iPSC-derived neural cells: implications for COVID-19-related CNS disorders |
Yoshitaka Kase, Hideyuki Okano |
| 20 |
[GO] |
2020―Aug―10 |
Genome evolution of SARS-CoV-2 and its virological characteristics |
So Nakagawa, Takayuki Miyazawa |
| 21 |
[GO] |
2020―Aug―06 |
Macrophage activation syndrome and COVID-19 |
Ryo Otsuka, Ken-ichiro Seino |
| 22 |
[GO] |
2020―Jun―22 |
Therapeutic potential of mesenchymal stem cells and their exosomes in severe novel coronavirus disease 2019 (COVID-19) cases |
Atsunori Tsuchiya, Suguru Takeuchi, Takahiro Iwasawa, Masaru Kumagai, Takeki Sato, Satoko Motegi, et al. (+14) Yui Ishii, Youhei Koseki, Kei Tomiyoshi, Kazuki Natsui, Nobutaka Takeda, Yuki Yoshida, Fusako Yamazaki, Yuichi Kojima, Yusuke Watanabe, Naruhiro Kimura, Kentaro Tominaga, Hiroteru Kamimura, Masaaki Takamura, Shuji Terai |
| 23 |
[GO] |
2020―Jun―22 |
Steps towards COVID-19 suppression |
Hideyuki Okano, Ken-ichiro Seino |
